HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS
申请人:Oligasis
公开号:US20140024776A1
公开(公告)日:2014-01-23
The present invention provides multi-armed high MW polymers containing hydrophilic groups and one or more functional agents, and methods of preparing such polymers.
PTERIDINE KETONE DERIVATIVE AND APPLICATIONS THEREOF AS EGFR, BLK, AND FLT3 INHIBITOR
申请人:EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
公开号:US20150126508A1
公开(公告)日:2015-05-07
Provided are a pteridine ketone derivative used as an EGFR, BLK, and FLT3 inhibitor and applications thereof. Specifically, provided are a compound of the following formula I, a pharmaceutical composition containing the compound of the formula I, and use of compound in preparing medicine for treating diseases mediated by EGFR, BLK, or FLT3 or inhibiting EGFR, BLK, and FLT3.
1-(3,4,5-Trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives represented by general formula (I): ##STR1## wherein R is a straight- or branched-chain alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 5 to 7 carbon atoms, and pharmaceutically acceptable acid addition salts thereof are disclosed. The 1-(3,4,5-trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives are useful as vasodilator agents.
1,2-Cycloadditions of 3-methyl-1-(methylthio)-1-butenyl isocyanate with N-t-butyl-α-toluenimine N-oxide and with in situ-generated N-t-butyl-α-methyl-α-lactam afforded an oxadiazolidinone derivative and a hydantoin derivative in 100 and 46% yields, respectively.
TARGETED DRUG PHOSPHORYLCHOLINE POLYMER CONJUGATES
申请人:Charles Stephen A.
公开号:US20130034517A1
公开(公告)日:2013-02-07
The present invention provides random copolymers containing phosphorylcholine and one or more functional agents, and methods of preparing such random copolymers.